Search research articles
Contact Us
Filters
Showing results (41-50 of 100) with videos related to
Page
of 10
Sort By:
Plant Physiology and Biochemistry : PPB
|
July 2, 2021
Overexpression of OsPHR3 improves growth traits and facilitates nitrogen use efficiency under low phosphate condition
Yafei Sun, Zhi Hu, Xiaowen Wang, et al.
The Oncologist
|
February 8, 2024
Exploring the Landscape of Immune Checkpoint Inhibitor-Induced Adverse Events Through Big Data Mining of Pan-Cancer Clinical Trials
Muhammad Zaki Hidayatullah Fadlullah, Ching-Nung Lin, Samuel Coleman, et al.
ACS Applied Materials & Interfaces
|
January 18, 2024
Luminescent Porous Organic Crystals for Adsorptive Separation of Toluene and Methylcyclohexane
Siwen Hu, He Zhao, Meng Liang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
September 4, 2025
Polymer-based chemo-immunotherapy: Combining immunogenic cell death induction and PD-L1 blockade enhances antitumor immunity in melanoma
Jiahui Li, Hasan Al Faruque, Emilio Cortes-Sanchez, et al.
Cancer Medicine
|
November 3, 2019
Real-world survival of patients with advanced BRAF V600 mutated melanoma treated with front-line BRAF/MEK inhibitors, anti-PD-1 antibodies, or nivolumab/ipilimumab
Justin C Moser, Danli Chen, Siwen Hu-Lieskovan, et al.
Small (Weinheim an Der Bergstrasse, Germany)
|
June 16, 2023
Flexible Luminescent Hydrogen-bonded Organic Framework for the Separation of Benzene and Cyclohexane
Meng Liang, Siwen Hu, Ningning Zhou, et al.
International Journal of Molecular Sciences
|
February 11, 2023
Mutation of <i>OsLPR3</i> Enhances Tolerance to Phosphate Starvation in Rice
Hao Ai, Xiuli Liu, Zhi Hu, et al.
Targeted Oncology
|
October 25, 2021
Association of Tumor Mutational Burden and Immune Gene Expression with Response to PD-1 Blockade by Sasanlimab Across Tumor Types and Routes of Administration
Siwen Hu-Lieskovan, Fadi Braiteh, Juneko E Grilley-Olson, et al.
JAMA Oncology
|
May 31, 2019
Assessment of Subcutaneous vs Intravenous Administration of Anti-PD-1 Antibody PF-06801591 in Patients With Advanced Solid Tumors: A Phase 1 Dose-Escalation Trial
Melissa L Johnson, Fadi Braiteh, Juneko E Grilley-Olson, et al.
Biorxiv : the Preprint Server for Biology
|
June 6, 2025
Comparison of QuPath and HALO platforms for analysis of the tumor microenvironment in prostate cancer
Wei Zhang, Qin Zhou, Jonathan V Nguyen, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 100) with videos related to
Sort By:
Page
of 10
Plant Physiology and Biochemistry : PPB
|
July 2, 2021
Overexpression of OsPHR3 improves growth traits and facilitates nitrogen use efficiency under low phosphate condition
Yafei Sun, Zhi Hu, Xiaowen Wang, et al.
The Oncologist
|
February 8, 2024
Exploring the Landscape of Immune Checkpoint Inhibitor-Induced Adverse Events Through Big Data Mining of Pan-Cancer Clinical Trials
Muhammad Zaki Hidayatullah Fadlullah, Ching-Nung Lin, Samuel Coleman, et al.
ACS Applied Materials & Interfaces
|
January 18, 2024
Luminescent Porous Organic Crystals for Adsorptive Separation of Toluene and Methylcyclohexane
Siwen Hu, He Zhao, Meng Liang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
September 4, 2025
Polymer-based chemo-immunotherapy: Combining immunogenic cell death induction and PD-L1 blockade enhances antitumor immunity in melanoma
Jiahui Li, Hasan Al Faruque, Emilio Cortes-Sanchez, et al.
Cancer Medicine
|
November 3, 2019
Real-world survival of patients with advanced BRAF V600 mutated melanoma treated with front-line BRAF/MEK inhibitors, anti-PD-1 antibodies, or nivolumab/ipilimumab
Justin C Moser, Danli Chen, Siwen Hu-Lieskovan, et al.
Small (Weinheim an Der Bergstrasse, Germany)
|
June 16, 2023
Flexible Luminescent Hydrogen-bonded Organic Framework for the Separation of Benzene and Cyclohexane
Meng Liang, Siwen Hu, Ningning Zhou, et al.
International Journal of Molecular Sciences
|
February 11, 2023
Mutation of <i>OsLPR3</i> Enhances Tolerance to Phosphate Starvation in Rice
Hao Ai, Xiuli Liu, Zhi Hu, et al.
Targeted Oncology
|
October 25, 2021
Association of Tumor Mutational Burden and Immune Gene Expression with Response to PD-1 Blockade by Sasanlimab Across Tumor Types and Routes of Administration
Siwen Hu-Lieskovan, Fadi Braiteh, Juneko E Grilley-Olson, et al.
JAMA Oncology
|
May 31, 2019
Assessment of Subcutaneous vs Intravenous Administration of Anti-PD-1 Antibody PF-06801591 in Patients With Advanced Solid Tumors: A Phase 1 Dose-Escalation Trial
Melissa L Johnson, Fadi Braiteh, Juneko E Grilley-Olson, et al.
Biorxiv : the Preprint Server for Biology
|
June 6, 2025
Comparison of QuPath and HALO platforms for analysis of the tumor microenvironment in prostate cancer
Wei Zhang, Qin Zhou, Jonathan V Nguyen, et al.
Page
of 10